Figure S4 from Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients

Léa Baudre; Grégoire Jouault; Pacôme Prompsy; Mélissa Saichi; Sarah Gastineau; Christophe Huret; Laura Sourd; Ahmed Dahmani; Élodie Montaudon; Florent Dingli; Damarys Loew; Elisabetta Marangoni; Justine Marsolier; Céline Vallot

doi:10.1158/0008-5472.31228747

Figure S4 from Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients

2026 Open access

Read full text

Authors: Léa Baudre, Grégoire Jouault, Pacôme Prompsy, Mélissa Saichi, Sarah Gastineau, Christophe Huret, Laura Sourd, Ahmed Dahmani, Élodie Montaudon, Florent Dingli, Damarys Loew, Elisabetta Marangoni

+2 more

Justine Marsolier, Céline Vallot

DOI: 10.1158/0008-5472.31228747

Cited by: 0

Abstract

FOSL1 expression increases the capacity of the cells to tolerate drug insult in vitro

Fields of Study & Subjects

Cancer Cells and Metastasis Breast Cancer Treatment Studies Cell death mechanisms and regulation

Publication details

Publication date: 2 February 2026